Combining Genomics and Imageomics to Predict the Sensitivity of Neoadjuvant Pemetrexed and Cisplatin Chemotherapy in Patients With Lung Adenocarcinoma
Clinical trial NCT05185544 · UNKNOWN
Trial details
- NCT number
- NCT05185544
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-01
- Primary completion
- 2024-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.